Blog
RSS FeedPosted by Michael Wonder on 23 Jan 2025
EU-HTA: maintaining the achievements of AMNOG
20 January 2025 - IQWiG welcomes the fact that the adjustments to the AMNOG procedure planned for the integration with European ...
Posted by Michael Wonder on 21 Jan 2025
Drug shortage crisis demands intervention, AMA warns, as patients struggle to secure medicines
20 January 2025 - There are more than 400 medicine shortages, and the country’s leading medical group blames it on ‘ad ...
Posted by Michael Wonder on 21 Jan 2025
Albertan with rare blood cancer calls on Health Canada to approve life-saving drug
20 January 2025 - An Alberta woman living with a rare form of blood cancer is calling on Health Canada ...
Posted by Michael Wonder on 20 Jan 2025
BIO statement on new list of medicines targeted for Government price setting
17 January 2025 - The Biotechnology Innovation Organization (BIO) today released the following statement after the Biden administration released a ...
Posted by Michael Wonder on 19 Jan 2025
Human medicines in 2024
16 January 2025 - In 2024, EMA recommended 114 medicines for marketing authorisation. ...
Posted by Michael Wonder on 19 Jan 2025
Long wait for cancer drug approvals causing 'great anguish' among patients, doctors
18 January 2025 - Potentially life-saving treatments delayed by bureaucracy, doctors say. ...
Posted by Michael Wonder on 19 Jan 2025
Ozempic among the next drugs up for Medicare price negotiations
17 January 2025 - List of drugs account for $41 billion in annual Medicare spending, Biden administration says. ...
Posted by Michael Wonder on 17 Jan 2025
HHS announces 15 additional drugs selected for Medicare drug price negotiations in continued effort to lower prescription drug costs for seniors
17 January 2025 - Medicare has selected 15 more drugs to negotiate directly with participating drug companies. Building on the ...
Posted by Michael Wonder on 12 Jan 2025
Vanda's letter to FDA Commissioner highlights faulty gastroparesis NDA review
8 January 2025 - Vanda Pharmaceuticals letter to FDA Commissioner highlights faulty gastroparesis NDA review. ...
Posted by Michael Wonder on 09 Jan 2025
CDER brings many safe and effective therapies to patients and consumers in 2024
8 January 2024 - Each year, the US FSA’s Center for Drug Evaluation and Research (CDER) evaluates and, as appropriate, approves ...
Posted by Michael Wonder on 02 Jan 2025
Save the Food and Drug Administration by breaking it up
2 January 2025 - Let’s separate the FDA into two distinct entities. ...
Posted by Michael Wonder on 27 Dec 2024
Labor leaves genetics loophole for life insurers
21 December 2024 - One of the last barriers to widespread genetic testing — discrimination against obtaining life insurance — ...
Posted by Michael Wonder on 24 Dec 2024
HHS announces cost savings for 64 prescription drugs thanks to the Medicare Prescription Drug Inflation Rebate Program established by the Biden-Harris Administration’s lower cost prescription drug law
20 December 2024 - Under the Inflation Reduction Act, some people with Medicare will pay less for some Part B ...
Posted by Michael Wonder on 22 Dec 2024
Givinostat conditionally approved to treat patients with Duchenne muscular dystrophy
20 December 2024 - The MHRA has today granted a conditional marketing authorisation for the medicine givinostat (Duvyzat) to treat Duchenne ...
Posted by Michael Wonder on 14 Dec 2024
Alofisel withdrawn from the EU market
13 December 2024 - Benefit of treatment used in Crohn’s disease no longer demonstrated. ...